 SOUTH SAN FRANCISCO, Calif., Oct. 12, 2022 GLOBE NEWSWIRE -- 23andMe Holding Co. Nasdaq: ME 23andMe, a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that management will be participating in investor presentations at the following conferences: 